Uncategorized STEVEN GROSSMAN 9/5/14 Uncategorized STEVEN GROSSMAN 9/5/14 A Heirarchy of Wishes (for FY 15 Appropriations) Read More Advocacy at a Glance STEVEN GROSSMAN 9/5/14 Advocacy at a Glance STEVEN GROSSMAN 9/5/14 FDA Approval of New Molecular Entity Drugs Up So Far in 2014 and more Read More Uncategorized STEVEN GROSSMAN 8/29/14 Uncategorized STEVEN GROSSMAN 8/29/14 The Short and the Long of FDA Advocacy Read More Uncategorized STEVEN GROSSMAN 8/29/14 Uncategorized STEVEN GROSSMAN 8/29/14 House Democrats Urge OMB and HHS to Request Food Safety Appropriations for FY 16, Not Food User Fees and more Read More Uncategorized STEVEN GROSSMAN 8/22/14 Uncategorized STEVEN GROSSMAN 8/22/14 If You're Booking Travel Plans for Late September ... Read More Advocacy at a Glance STEVEN GROSSMAN 8/22/14 Advocacy at a Glance STEVEN GROSSMAN 8/22/14 Commissioner Makes Strategic Speaking Plans and more Read More Uncategorized STEVEN GROSSMAN 8/15/14 Uncategorized STEVEN GROSSMAN 8/15/14 As the Election Nears ... Changes in Committee Memberships? Read More Advocacy at a Glance STEVEN GROSSMAN 8/15/14 Advocacy at a Glance STEVEN GROSSMAN 8/15/14 FDA Research: An Example of Regulatory Science in Action and more Read More Advocacy at a Glance STEVEN GROSSMAN 8/8/14 Advocacy at a Glance STEVEN GROSSMAN 8/8/14 Appropriations Update and more Read More Uncategorized STEVEN GROSSMAN 8/8/14 Uncategorized STEVEN GROSSMAN 8/8/14 Gearing Up for "FDA 101" ... Starting in the Fall Read More Uncategorized STEVEN GROSSMAN 8/2/14 Uncategorized STEVEN GROSSMAN 8/2/14 Can Congress Muster the Will to Compromise ... on Something? Read More Advocacy at a Glance STEVEN GROSSMAN 8/2/14 Advocacy at a Glance STEVEN GROSSMAN 8/2/14 FDA Funding/Focus on CDER Resources and more Read More Uncategorized STEVEN GROSSMAN 7/26/14 Uncategorized STEVEN GROSSMAN 7/26/14 FY 15 Appropriations: Macro- and Micro-Budgetary Drivers Redux Read More Advocacy at a Glance STEVEN GROSSMAN 7/26/14 Advocacy at a Glance STEVEN GROSSMAN 7/26/14 Congressional Momentum on Appropriations: Sinking Fast But Not Yet Gone and more Read More Uncategorized STEVEN GROSSMAN 7/18/14 Uncategorized STEVEN GROSSMAN 7/18/14 Where There's No Will, There's No Way Read More Advocacy at a Glance STEVEN GROSSMAN 7/18/14 Advocacy at a Glance STEVEN GROSSMAN 7/18/14 CBO Releases Long-Term Budget Outlook Projecting Smaller Deficits Through 2018 and more Read More Uncategorized STEVEN GROSSMAN 7/11/14 Uncategorized STEVEN GROSSMAN 7/11/14 Reeling, Writhing, Drawling, Stretching, and Fainting in Coils Read More Advocacy at a Glance STEVEN GROSSMAN 7/11/14 Advocacy at a Glance STEVEN GROSSMAN 7/11/14 FDASIA: Just 2 Years Ago and more Read More Uncategorized STEVEN GROSSMAN 6/27/14 Uncategorized STEVEN GROSSMAN 6/27/14 No FDA-Related News Scheduled for July 4, 2014 Read More Uncategorized STEVEN GROSSMAN 6/27/14 Uncategorized STEVEN GROSSMAN 6/27/14 FDA's FY 16 Budget Already on the Table Read More Newer Posts Older Posts
Uncategorized STEVEN GROSSMAN 9/5/14 Uncategorized STEVEN GROSSMAN 9/5/14 A Heirarchy of Wishes (for FY 15 Appropriations) Read More
Advocacy at a Glance STEVEN GROSSMAN 9/5/14 Advocacy at a Glance STEVEN GROSSMAN 9/5/14 FDA Approval of New Molecular Entity Drugs Up So Far in 2014 and more Read More
Uncategorized STEVEN GROSSMAN 8/29/14 Uncategorized STEVEN GROSSMAN 8/29/14 The Short and the Long of FDA Advocacy Read More
Uncategorized STEVEN GROSSMAN 8/29/14 Uncategorized STEVEN GROSSMAN 8/29/14 House Democrats Urge OMB and HHS to Request Food Safety Appropriations for FY 16, Not Food User Fees and more Read More
Uncategorized STEVEN GROSSMAN 8/22/14 Uncategorized STEVEN GROSSMAN 8/22/14 If You're Booking Travel Plans for Late September ... Read More
Advocacy at a Glance STEVEN GROSSMAN 8/22/14 Advocacy at a Glance STEVEN GROSSMAN 8/22/14 Commissioner Makes Strategic Speaking Plans and more Read More
Uncategorized STEVEN GROSSMAN 8/15/14 Uncategorized STEVEN GROSSMAN 8/15/14 As the Election Nears ... Changes in Committee Memberships? Read More
Advocacy at a Glance STEVEN GROSSMAN 8/15/14 Advocacy at a Glance STEVEN GROSSMAN 8/15/14 FDA Research: An Example of Regulatory Science in Action and more Read More
Advocacy at a Glance STEVEN GROSSMAN 8/8/14 Advocacy at a Glance STEVEN GROSSMAN 8/8/14 Appropriations Update and more Read More
Uncategorized STEVEN GROSSMAN 8/8/14 Uncategorized STEVEN GROSSMAN 8/8/14 Gearing Up for "FDA 101" ... Starting in the Fall Read More
Uncategorized STEVEN GROSSMAN 8/2/14 Uncategorized STEVEN GROSSMAN 8/2/14 Can Congress Muster the Will to Compromise ... on Something? Read More
Advocacy at a Glance STEVEN GROSSMAN 8/2/14 Advocacy at a Glance STEVEN GROSSMAN 8/2/14 FDA Funding/Focus on CDER Resources and more Read More
Uncategorized STEVEN GROSSMAN 7/26/14 Uncategorized STEVEN GROSSMAN 7/26/14 FY 15 Appropriations: Macro- and Micro-Budgetary Drivers Redux Read More
Advocacy at a Glance STEVEN GROSSMAN 7/26/14 Advocacy at a Glance STEVEN GROSSMAN 7/26/14 Congressional Momentum on Appropriations: Sinking Fast But Not Yet Gone and more Read More
Uncategorized STEVEN GROSSMAN 7/18/14 Uncategorized STEVEN GROSSMAN 7/18/14 Where There's No Will, There's No Way Read More
Advocacy at a Glance STEVEN GROSSMAN 7/18/14 Advocacy at a Glance STEVEN GROSSMAN 7/18/14 CBO Releases Long-Term Budget Outlook Projecting Smaller Deficits Through 2018 and more Read More
Uncategorized STEVEN GROSSMAN 7/11/14 Uncategorized STEVEN GROSSMAN 7/11/14 Reeling, Writhing, Drawling, Stretching, and Fainting in Coils Read More
Advocacy at a Glance STEVEN GROSSMAN 7/11/14 Advocacy at a Glance STEVEN GROSSMAN 7/11/14 FDASIA: Just 2 Years Ago and more Read More
Uncategorized STEVEN GROSSMAN 6/27/14 Uncategorized STEVEN GROSSMAN 6/27/14 No FDA-Related News Scheduled for July 4, 2014 Read More
Uncategorized STEVEN GROSSMAN 6/27/14 Uncategorized STEVEN GROSSMAN 6/27/14 FDA's FY 16 Budget Already on the Table Read More
